A tiny organoid-based test can rapidly predict the effectiveness of lung cancer drugs, speeding up personalised drug testing and decision making in treatments. Drug testing has long been associated...
A collaboration between Hummingbird Bioscience and MD Anderson will serve to investigate and evaluate Hummingbird’s HMBD-002 VISTA antagonist antibody. Hummingbird Bioscience, an innovative...
In this article, Dr Daniel Tan introduces Tumour Treating Fields, a promising therapy for patients with glioblastoma multiforme. Glioblastoma multiforme or GBM is a feared, lethal and aggressive...
Renal cell carcinoma is the most common malignancy of the kidney. Its incidence has been steadily increasing over the past few decades. There are several reasons for this. Firstly, abdominal scans...
Researchers from High Magnetic Field Laboratory of the Hefei Institutes of Physical Science (HFIPS), in a collaboration with a lab from the Institute of Biophysics, reported the structural basis of a...
Duke-NUS scientists identify MBNL1 as a cancer biomarker associated with poorer disease outcomes, opening new doors for cancer therapeutics. Cancer incidence worldwide continues to increase, with the...
